Cartesian Therapeutics Inc. (RNAC)
Market Closed
1 Sep, 20:00
$
9. 30
+0.02
+0.2155%
Pre Market
$
+0.05 +0.5376% 9. 35
292.93M Market Cap
- P/E Ratio
- Div Yield
112,137 Volume
- Eps
$ 9.28
Previous Close Investors:
Want to track RNAC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cartesian Therapeutics Inc. (RNAC) Statistics
Valuation metrics
Market Cap 292.93M
Enterprise value 198.31M
Trailing P/E (ttm) -1.62
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 190.97
Price/Book (mrq) -2.26
Enterprise Value/Revenue 134.26
Enterprise Value/EBITDA -1.26
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 65.55K
Average volume (90 days) 292.55K
Price summary
52-Week low 5.6
52-Week high 11
Beta -
50-Day moving average 8.42
200-Day moving average 7.23
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 5 Apr 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -104.22%
Operating margin -66.8%
Operational effectiveness
Return on assets -0.48%
Return on equity 1.41%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.01
Total debt (mrq) -
Total Debt/Equity (mrq) -0.51
Current ratio (mrq) 7.48%
Book value per share (mrq) -4.25
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
